Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica)
| Autor: | Roberta Ghilardi, Francesca Fioredda, Gabriella Casazza, Anna Pusiol, Michaela Calvillo, Ugo Ramenghi, Giovanni Palazzi, Baldassarre Martire, Marina Lanciotti, Fabio Tucci, Piero Farruggia, Angelica Barone, Tiziana Coliva, Daniela Renga, Carlo Dufour, Eleonora Gambineri, Giuseppe Menna, Sonia Bonanomi, Marta Pillon |
|---|---|
| Přispěvatelé: | Fioredda, F, Calvillo, M, Bonanomi, S, Coliva, T, Tucci, F, Farruggia, P, Pillon, M, Martire, B, Ghilardi, R, Ramenghi, U, Renga, D, Menna, G, Pusiol, A, Barone, A, Gambineri, E, Palazzi, G, Casazza, G, Lanciotti, M, Dufour, C |
| Jazyk: | angličtina |
| Rok vydání: | 2012 |
| Předmět: |
Pediatrics
medicine.medical_specialty Consensus Neutropenia Bone marrow transplantation MEDLINE Consensu Transplantation Autologous Drug Administration Schedule Bone Marrow Antineoplastic Combined Chemotherapy Protocols Granulocyte Colony-Stimulating Factor Medicine Humans Transplantation Homologous In patient Disease management (health) Child Transplantation Homologou Bone Marrow Transplantation Antineoplastic Combined Chemotherapy Protocol business.industry Disease Management Hematology MED/38 - PEDIATRIA GENERALE E SPECIALISTICA medicine.disease Transplantation Transplantation Autologou business Human |
| Popis: | The management of congenital and acquired neutropenias presents some differences according to the type of the disease. Treatment with recombinant human granulocyte-colony stimulating factor (G-CSF) is not standardized and scanty data are available on the best schedule to apply. The frequency and the type of longitudinal controls in patients affected with neutropenias are not usually discussed in the literature. The Neutropenia Committee of the Marrow Failure Syndrome Group (MFSG) of the Associazione Italiana di Emato-Oncologia Pediatrica (AIEOP) elaborated this document following design and methodology formerly approved by the AIEOP board. The panel of experts reviewed the literature on the topic and participated in a conference producing a document that includes recommendations on neutropenia treatment and timing of follow-up. © 2011 Wiley Periodicals, Inc. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|